Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics

Journal of Medicinal Chemistry

Volumn 47, Issue 24, 2004, Pages 5837-5846

  Gust, Ronald ^a   Ott, Ingo ^a   Posselt, Diana ^a   Sommer, Klaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

[1,3,4,6 TETRAKIS(2 HYDROXYPHENYL) 2,5 DIAZAHEXA 1,5 DIENE]COBALT; [1,6 BIS(2 HYDROXYPHENYL) 3,4 BIS(2 METHOXYPHENYL) 2,5 DIAZAHEXA 1,5 DIENE]COBALT; [1,6 BIS(2 HYDROXYPHENYL) 3,4 BIS(3 HYDROXYPHENYL) 2,5 DIAZAHEXA 1,5 DIENE]COBALT; [1,6 BIS(2 HYDROXYPHENYL) 3,4 BIS(3 METHOXYPHENYL) 2,5 DIAZAHEXA 1,5 DIENE]COBALT; [1,6 BIS(2 HYDROXYPHENYL) 3,4 BIS(4 METHOXYPHENYL) 2,5 DIAZAHEXA 1,5 DIENE]COBALT; ANTINEOPLASTIC AGENT; CELL DNA; CISPLATIN; COBALT COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CATALYSIS; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTEREOISOMER; DNA DAMAGE; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; AZA COMPOUNDS; CATALYSIS; CELL LINE, TUMOR; CHELATING AGENTS; COBALT; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 8644228546     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040763n     Document Type: Article

References (28)

1. Rosenberg, B.; VanCamp, B.; Krigas, T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 1965, 205, 698-699.
2. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Platinum compounds: a new class of potent antitumour agents. Nature 1969, 385-386.
3. Schmidt, K.; Jung, M.; Keilitz, R.; Schnurr, B.; Gust, R. Acetylenehexacarbonyldicobalt complexes, a novel class of antitumor drugs. Inorg. Chim. Acta 2000, 306, 6-16.
4. Ott, I.; Kirchner, B.; Gust, R. Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptake. J. Inorg. Biochem. 2004, 98, 485-489.
5. Niederhoffer, E. C.; Timmons, J. H.; Martell, A. E. Thermodynamics of oxygen binding in natural and synthetic dioxygen complexes. Chem. Rev. 1984, 84, 137-146.
6. Nackerdien, Z.; Kasprzak, K. S.; Rao, G.; Halliwell, B.; Dizdaroglu, M. Nickel(II)- and cobalt(II)-dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin. Cancer Res. 1991, 51, 5837-5842.
7. Robison, S. H.; Cantoni, O.; Costa, M. Strand breakage and decreased molecular weight of DNA induced by specific metal compounds. Carcinogenesis 1982, 3, 657-662.
8. Jennerwein, M.; Wappes, B.; Gust, R.; Schönenberger, H.; Engel, J.; Seeber, S.; Osieka, R. Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. J. Cancer Res. Clin. Oncol. 1998, 114, 347-358.
9. Müller, R.; Gust, R.; Bernhardt, G.; Keller, C.; Schönenberger, H.; Seeber, S.; Osieka, R.; Eastman, A.; Jennerwein, M. DL-1,2-bis(2- hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. J. Cancer Res. Clin. Oncol. 1990, 116, 237-244.
10. Schertl, S.; Gust, R.; Müller, R.; Spruss, T.; Schönenberger, H. Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, Part III: Evaluation of the mammary tumor inhibiting properties. Arch. Pharm. (Weinheim, Ger.) 1992, 325, 113-118.
11. Spruss, T.; Gust, R.; Müller, R.; Engel, J.; Schönenberger, H. Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complex. Arch. Pharm. (Weinheim, Ger.) 1990, 323, 99-102.
12. Jennerwein, M.; Gust, R.; Müller, R.; Schönenberger, H.; Engel, J.; Berger, M. R.; Schmähl, D.; Seeber, S.; Osieka, R.; Atassi, G. Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl) ethylenediamine]dichloroplatinum(II) complexes, Part I: Synthesis. Arch. Pharm. (Weinheim, Ger.) 1989, 322, 25-29.
13. Barkelew, C. H.; Calvin, M. The oxygen-carrying synthetic chelate compounds. II. The rates of oxygenation of the solid compounds. J. Am. Chem. Soc. 1946, 68, 2257-2262.
14. Van Dort, H. M.; Geursen, H. J. Salcomine-catalyzed oxidations of some phenols. A new method for the preparation of a number of p-benzoquinones. Recl. Trav. Chim. Pays-Bas 1967, 86, 520-526.
15. Nishinaga, A.; Tomita, H.; Tarumi, Y.; Matsuura, T. Reaction of superoxo cobalt(III) complexes with 2,6-di-tert-butyl-p-benzoquinone methides. Tetrahedron Lett. 1980, 21, 4849-4852.
16. Zombeck, A.; Drago, R. S.; Corden, B. B.; Gaul, J. H. Activation of molecular oxygen. Kinetic studies of the oxidation of hindered phenols with cobalt-dioxygen complexes. J. Am. Chem. Soc. 1981, 103, 7580-7585.
17. Bernhardt, G.; Reile, H.; Birnböck, H.; Spruss, T.; Schönenberger, H. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J. Res. Clin. Oncol. 1992, 118, 35-43.
18. Bernhardt, B.; Koch, M.; Spruss, T.; Gust, R.; Krauser, R.; Schlemmer, R.; Schönenberger H. [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]sulfatoplatinum(II). Pharmacokinetic Studies. Arch. Pharm. (Weinheim, Ger.) 1999, 332, 195-200.
19. Boulikas, T.; Vougiouka, M. Cisplatin and platinum drugs at the molecular level (review). Oncol. Rep. 2003, 10, 1663-1682.
20. Reile, H.; Bernhardt, G.; Koch, M.; Schönenberger, H.; Hollstein, M.; Lux, F. Chemosensitivity of human MCF-7 breast cancer cells to diastereomeric diaqua(1,2-diphenylethylenediamine)-platinum(II) sulfates and specific platinum accumulation. Cancer Chemother. Pharmacol. 1992, 30, 113-122.
21. Gall, R. S.; Rogers, J. F.; Schaefer, W. P.; Christoph, G. G. The structure of a monomeric oxygen carrying cobalt complex: dioxygen-N,N′-(1, 1,2,2-tetramethyl)ethylenebis(3-tert-butylsalicylideniminato)(1-benzylimidazole) cobalt(II). J. Am. Chem. Soc. 1976, 98, 5135-5138.
22. Avdeef, A.; Schaefer, W. P. Reversible oxygen carriers. The synthesis and low temperature (-171β) structure of an unstable monomeric dioxygen adduct of N,N′-(1,1,2,2-tetramethyl)ethylenebis(3-fluorosalicylideniminato)(1- methylimidazole)cobalt(II), Co(3-F-Saltmen)(1-Me-Imid)(O2).2Me2CO. J. Am. Chem. Soc. 1976, 98, 5153-5161.
23. Brückner, S.; Calligaris, M.; Nardi, G.; Randaccio, L. Crystal and molecular structure of (1-diacetyl-monoximatoimino-3-diacetylmonoximeimino- propane)methylaquocobalt(III) perchlorate. Inorg. Chim. Acta 1969, 3, 308-330.
24. Liu, G.-D.; Yang, X.; Chen, Z.-P.; Shen, G.-L.; Yu, R.-Q. Interaction of metal complexes of bis(salicylidene)ethylenediamine with DNA. Anal. Sci. 2000, 16, 1255-1259.
25. Routier, S.; Joanny, V.; Zaparucha, A.; Vezin, H.; Catteau, J.-P.; Bernier, J.-L.; Bailly, C. Synthesis of metal complexes of 2,9-bis(2- hydroxyphenyl)-1,10-phenantroline and their DNA binding and cleaving activities. J. Chem. Soc., Perkin Trans. 2 1998, 863-868.
26. Hay, R. J. The seed stock concept and quality control for cell lines. Anal. Biochem. 1988, 171, 225-237.
27. Reile, H.; Birnböck, H.; Bernhardt, G.; Spruss, T.; Schönenberger, H. Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal. Biochem. 1990, 187, 262-267.
28. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.